Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs

Pancreatic ductal adenocarcinoma (PDAC) is characterised by a pro-inflammatory stroma and multi-faceted microenvironment that promotes and maintains tumorigenesis. However, the models used to test new and emerging therapies for PDAC have not increased in complexity to keep pace with our understandin...

Descripción completa

Detalles Bibliográficos
Autores principales: Brumskill, Sarah, Barrera, Lawrence N., Calcraft, Peter, Phillips, Caroline, Costello, Eithne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905179/
https://www.ncbi.nlm.nih.gov/pubmed/34865180
http://dx.doi.org/10.1007/s13105-021-00857-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905179/
https://www.ncbi.nlm.nih.gov/pubmed/34865180
http://dx.doi.org/10.1007/s13105-021-00857-2

Ejemplares similares